IFNG and inflammatory bowel disease: In addition, the combination of IFN-γ, IL-17A/F and IL-23, referred to in the present study as cytokine combination, was designed for a disease model such as inflammatory bowel disease (IBD) or experimental autoimmune encephalomyelitis (EAE) [63].